Discovery of C19-9 as a novel non-RGD inhibitor of alpha v beta 3 to overcome enzalutamide resistance in castration-resistant prostate cancer
SIGNAL TRANSDUCTION AND TARGETED THERAPY（2023）
Key words
Drug development,Drug screening,Medicine/Public Health,general,Internal Medicine,Cancer Research,Cell Biology,Pathology,Oncology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined